Human IL-2 ELISA Kit检测试剂盒(酶联免疫吸附法)
¥1,600.00 – ¥10,800.00
在售SKU:70-EK102-48, 70-EK102-96, EK102, 人白介素2, 白介素2, 人, 白介素, 2
- 分子靶点:IL2
- 种属:人
- 样本类型:血清、血浆、细胞培养上清及其他生物学样本
- 检测样本体积:血清、血浆样本50μL
- 灵敏度:0.36pg/mL
- 检测范围:7.81-500pg/mL
- 回收率:86%-97%
ELISA试剂盒详细信息
商品名 | 人白介素2酶联免疫检测试剂盒 |
---|---|
种属 | 人 |
靶点 | IL2 |
检测方法 | 双抗体夹心法 |
检测样本类型 | 血清、血浆、细胞培养上清及其他生物学样本 |
检测样本体积 | 血清、血浆样本50μL |
灵敏度 | 0.36pg/mL |
线性范围 | 7.81-500pg/mL |
精密度 | 板内变异系数:2.5%-3.6%;板间变异系数:3.2%-7.0% |
回收率 | 86%-97% |
平均回收率 | 91% |
板式 | 96孔板,可拆 |
保存条件 | 2-8℃保存。已拆开:标准品-20℃保存,其它4℃。 |
运输条件 | 2-8℃冰袋运输 |
检测原理 | 本试剂盒采用双抗体夹心酶联免疫吸附检测技术。特异性捕获抗体预包被在高亲和力的酶标板上。酶标板孔中加入标准品、待测样本和生物素化的检测抗体,经过孵育,样本中存在的待测物质与捕获抗体和检测抗体结合。洗涤去除未结合的物质后,加入辣根过氧化物酶标记的链霉亲和素(Streptavidin-HRP)。洗涤后,加入显色底物(TMB),避光显色。颜色反应的深浅与样本中待测物质的浓度成正比。加入终止液终止反应,在450nm波长(参考波长570 - 630nm)测定吸光度值。 |
分子信息
IL2 分子靶点信息概述
- 分子名:IL2, interleukin 2
- 基因家族:Interleukins
- 别名:IL-2; TCGF
- 全称:T cell growth factor
IL2 分子靶点综述
白细胞介素2(IL-2)是15kDa的糖蛋白,在人类中,由位于4号染色体q26–28区域的单基因编码。它是免疫系统中的一类信号分子,调控对具有免疫功能的白血球(白细胞,通常是淋巴细胞)的活性。IL-2是机体对微生物感染的天然应答,区别外来和自身抗原。IL-2通过与IL-2受体来发挥功能,其受体由3条链组成,分别为α链(CD25)、β链(CD122)和γ链(CD132)。监测血清中的IL-2含量为多种病理状态提供更详细的视角,包括癌症、传染病、移植排斥、多发性硬化症、类风湿性关节炎、系统性红斑狼疮和I型糖尿病等。
人 Human IL2 分子靶点信息
- 分子名:IL2, interleukin 2
- 别称:
- aldesleukin
- IL-2
- interleukin-2
- involved in regulation of T-cell clonal expansion
- lymphokine
- T cell growth factor
- TCGF
- 基因序列:NCBI_Gene: 3558
- 蛋白序列:UniProtKB: P60568
人 Human IL2靶点分子功能(预测)
Enables cytokine activity and interleukin-2 receptor binding activity. Involved in leukocyte activation involved in immune response; positive regulation of interleukin-17 production; and positive regulation of tyrosine phosphorylation of STAT protein. Acts upstream of or within negative regulation of B cell apoptotic process; positive regulation of B cell proliferation; and positive regulation of activated T cell proliferation. Predicted to be located in extracellular space. Implicated in several diseases, including Takayasu's arteritis; auditory system disease (multiple); autoimmune disease (multiple); carcinoma (multiple); and neurodegenerative disease (multiple). Biomarker of several diseases, including Zellweger syndrome; aggressive periodontitis; anogenital venereal wart; autoimmune disease (multiple); and uveitis (multiple).
引用文献统计
该产品被引用的文献总数为:80
- Inflammatory Cytokines Changed in Patients With Depression Before and After Repetitive Transcranial Magnetic Stimulation Treatment
影响因子:5.435刊物:Frontiers in Psychiatry发表日期:2022/6/2 - Vitamin D deficiency is associated with thyroid autoimmunity: results from an epidemiological survey in Tianjin, China
影响因子:3.633刊物:ENDOCRINE发表日期:2021/3/23 - Original research: Shed antigen-induced blocking effect on CAR-T cells targeting Glypican-3 in Hepatocellular Carcinoma
影响因子:13.751刊物:Journal for ImmunoTherapy of Cancer发表日期:2021/4/8 - Reducing Hinge Flexibility of CAR-T Cells Prolongs Survival In Vivo With Low Cytokines Release
影响因子:7.561刊物:Frontiers in Immunology发表日期:2021/10/5 - Adoptive immunotherapy using T lymphocytes redirected to glypican-3 for the treatment of lung squamous cell carcinoma
影响因子:6.359刊物:Oncotarget发表日期:2015/12/14 - Development of bispecific anti-c-Met/PD-1 diabodies for the treatment of solid tumors and the effect of c-Met binding affinity on efficacy
影响因子:8.11刊物:OncoImmunology发表日期:2021/7/21 - Preclinical characterization of a Fab-like CD3/CLDN18.2 XFab® bispecific antibody against solid tumors
影响因子:3.152刊物:IMMUNOBIOLOGY发表日期:2022/9/30 - Cytokine-induced killer cells efficiently kill stem-like cancer cells of nasopharyngeal carcinoma via the NKG2D-ligands recognition
影响因子:6.359刊物:Oncotarget发表日期:2015/9/16 - JAK-STAT Domain Enhanced MUC1-CAR-T Cells Induced Esophageal Cancer Elimination
影响因子:2.886刊物:Cancer Management and Research发表日期:2020/10/8 - Chimeric cytokine receptor enhancing PSMA-CAR-T cell-mediated prostate cancer regression
影响因子:3.659刊物:CANCER BIOLOGY & THERAPY发表日期:2020/3/25 - Treatment of hepatocellular carcinoma with a GPC3-targeted bispecific T cell engager
影响因子:5.168刊物:Oncotarget发表日期:2017/5/16 - Development of GPC3 and EGFR-dual-targeting chimeric antigen receptor-T cells for adoptive T cell therapy
影响因子:4.06刊物:American Journal of Translational Research发表日期:2021/1/15 - Selective Targeting of Glioblastoma with EGFRvIII/EGFR Bitargeted Chimeric Antigen Receptor T Cell
影响因子:9.188刊物:Cancer Immunology Research发表日期:2018/11/2 - Claudin18.2-Specific Chimeric Antigen Receptor Engineered T Cells for the Treatment of Gastric Cancer
影响因子:11.238刊物:JNCI-Journal of the National Cancer Institute发表日期:2018/9/6 - Treatment Efficacy of Chuang Ling Ye, a Traditional Chinese Herbal Medicine Compound, on Idiopathic Granulomatous Mastitis: A Randomized Controlled Trial
影响因子:1.813刊物:Evidence-based Complementary and Alternative Medicine发表日期:2020/6/29 - Engineered IL-7 Receptor Enhances the Therapeutic Effect of AXL-CAR-T Cells on Triple-Negative Breast Cancer
影响因子:2.276刊物:Biomed Research International发表日期:2020/1/8 - Nanobody-based CAR T cells targeting intracellular tumor antigens
影响因子:7.419刊物:BIOMEDICINE & PHARMACOTHERAPY发表日期:2022/10/27 - A PD-1 peptide antagonist exhibits potent anti-tumor and immune regulatory activity
影响因子:7.36刊物:CANCER LETTERS发表日期:2020/8/15 - Design and Synthesis of A PD-1 Binding Peptide and Evaluation of Its Anti-Tumor Activity
影响因子:4.183刊物:INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES发表日期:2019/1/29 - Development of T Cells Redirected to Glypican-3 for the Treatment of Hepatocellular Carcinoma
影响因子:8.193刊物:CLINICAL CANCER RESEARCH发表日期:2014/12/14 - Disruption of PD-1 Enhanced the Anti-tumor Activity of Chimeric Antigen Receptor T Cells Against Hepatocellular Carcinoma
影响因子:3.831刊物:Frontiers in Pharmacology发表日期:2018/10/1 - Changes in peripheral blood cytokines in patients with severe fever with thrombocytopenia syndrome
影响因子:2.327刊物:JOURNAL OF MEDICAL VIROLOGY发表日期:2021/2/16 - Different effects of lipoteichoic acid from C. butyricum and S. aureus on inflammatory responses of HT-29 cells
影响因子:3.138刊物:INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES发表日期:2016/3/9 - The clinical study on treatment of CD19-directed chimeric antigen receptor-modified T cells in a case of refractory Richter syndrome
影响因子:3.357刊物:Cancer Medicine发表日期:2019/5/2 - Protective Effect of Hedyotis diffusa Willd. Ethanol Extract on Isoniazid-Induced Liver Injury in the Zebrafish Model
影响因子:4.319刊物:Drug Design Development and Therapy发表日期:2022/6/27 - Regulation of CBL and ESR1 expression by microRNA-22‑3p, 513a-5p and 625-5p may impact the pathogenesis of dust mite-induced pediatric asthma
影响因子:2.348刊物:INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE发表日期:2016/6/9 - Hyperbaric Oxygen Alleviates the Inflammatory Response Induced by LPS Through Inhibition of NF-κB/MAPKs-CCL2/CXCL1 Signaling Pathway in Cultured Astrocytes
影响因子:2.884刊物:INFLAMMATION发表日期:2018/8/3 - Increased antitumor activities of glypican-3-specific chimeric antigen receptor-modified T cells by coexpression of a soluble PD1–CH3 fusion protein
影响因子:4.225刊物:CANCER IMMUNOLOGY IMMUNOTHERAPY发表日期:2018/8/4 - Significantly increased anti-tumor activity of carcinoembryonic antigen-specific chimeric antigen receptor T cells in combination with recombinant human IL-12
影响因子:3.357刊物:Cancer Medicine发表日期:2019/6/25 - Antigen presentation of the Oct4 and Sox2 peptides by CD154-activated B lymphocytes enhances the killing effect of cytotoxic T lymphocytes on tumor stem-like cells derived from cisplatin-resistant lung cancer cells
影响因子:3.249刊物:Journal of Cancer发表日期:2018/1/1 - Accurate control of dual-receptor-engineered T cell activity through a bifunctional anti-angiogenic peptide
影响因子:7.333刊物:Journal of Hematology & Oncology发表日期:2018/3/20 - Armored Inducible Expression of IL-12 Enhances Antitumor Activity of Glypican-3–Targeted Chimeric Antigen Receptor–Engineered T Cells in Hepatocellular Carcinoma
影响因子:4.718刊物:JOURNAL OF IMMUNOLOGY发表日期:2019/7/1 - Effect of laser therapy on expression of angio- and fibrogenic factors, and cytokine concentrations during the healing process of human pressure ulcers
影响因子:2.284刊物:International Journal of Medical Sciences发表日期:2018/7/13 - Expression of coinhibitory PD-L1 on CD4+CD25+FOXP3+ regulatory T cells is elevated in patients with acute coronary syndrome
影响因子:1.497刊物:CORONARY ARTERY DISEASE发表日期:2015/11/1 - Recognition and killing of cancer stem-like cell population in hepatocellular carcinoma cells by cytokine-induced killer cells via NKG2d-ligands recognition
影响因子:7.644刊物:OncoImmunology发表日期:2016/3/21 - Efficacy and safety of low-dose interleukin-2 in combination with methotrexate in patients with active rheumatoid arthritis: a randomized, double-blind, placebo-controlled phase 2 trial
影响因子:38.104刊物:Signal Transduction and Targeted Therapy发表日期:2022/3/7 - Infant immune response to hepatitis B vaccine after fetal exposure to telbivudine
影响因子:4.526刊物:Human Vaccines & Immunotherapeutics发表日期:2022/3/16 - IFN-γ and TNF-α aggravate endothelial damage caused by CD123-targeted CAR T cell
影响因子:3.046刊物:OncoTargets and Therapy发表日期:2019/6/24 - Anemoside A3 activates TLR4-dependent M1-phenotype macrophage polarization to represses breast tumor growth and angiogenesis
影响因子:4.219刊物:TOXICOLOGY AND APPLIED PHARMACOLOGY发表日期:2021/10/18 - Upregulation of MicroRNA 711 Mediates HIV-1 Vpr Promotion of Kaposi's Sarcoma-Associated Herpesvirus Latency and Induction of Pro-proliferation and Pro-survival Cytokines by Targeting the Notch/NF-κB-Signaling Axis
影响因子:4.368刊物:JOURNAL OF VIROLOGY发表日期:2018/9/15 - A novel membrane-bound interleukin-2 promotes NK-92 cell persistence and anti-tumor activity
影响因子:7.723刊物:OncoImmunology发表日期:2022/9/22 - Development of T cells carrying two complementary chimeric antigen receptors against glypican-3 and asialoglycoprotein receptor 1 for the treatment of hepatocellular carcinoma
影响因子:4.846刊物:CANCER IMMUNOLOGY IMMUNOTHERAPY发表日期:2016/12/29 - EGLIF-CAR-T Cells Secreting PD-1 Blocking Antibodies Significantly Mediate the Elimination of Gastric Cancer
影响因子:2.886刊物:Cancer Management and Research发表日期:2020/9/23 - Secretion of human soluble programmed cell death protein 1 by chimeric antigen receptor-modified T cells enhances anti-tumor efficacy
影响因子:4.218刊物:CYTOTHERAPY发表日期:2020/7/17 - Enhanced Safety and Antitumor Efficacy of Switchable Dual Chimeric Antigen Receptor-Engineered T Cells against Solid Tumors through a Synthetic Bifunctional PD-L1-Blocking Peptide
影响因子:14.612刊物:Journal of the American Chemical Society发表日期:2020/9/23 - Ultrasound-Guided Percutaneous Transhepatic Gallbladder Drainage Improves the Prognosis of Patients with Severe Acute Cholecystitis
影响因子:2.65刊物:Evidence-based Complementary and Alternative Medicine发表日期:2022/8/29 - A metagenome-wide association study of the gut microbiota in recurrent aphthous ulcer and regulation by thalidomide.
影响因子:8.786刊物:Frontiers in Immunology发表日期:2022/10/19 - Engineered triple inhibitory receptor resistance improves anti-tumor CAR-T cell performance via CD56
影响因子:11.878刊物:Nature Communications发表日期:2019/9/11 - Engineering of α-PD-1 antibody-expressing long-lived plasma cells by CRISPR/Cas9-mediated targeted gene integration
影响因子:6.304刊物:Cell Death & Disease发表日期:2020/11/12 - 32A9, a novel human antibody for designing an immunotoxin and CAR-T cells against glypican-3 in hepatocellular carcinoma
影响因子:4.124刊物:Journal of Translational Medicine发表日期:2020/8/3 - SHTXTHHly, an extracellular secretion platform for the preparation of bioactive peptides and proteins in Escherichia coli
影响因子:6.352刊物:Microbial Cell Factories发表日期:2022/6/27 - Pyk2/MCU Pathway as a New Target for Reversing Atherosclerosis
影响因子:6.684刊物:Frontiers in Cell and Developmental Biology发表日期:2021/5/6 - Analysis of translation control tumor protein related to deltamethrin stress in Drosophila kc cells
影响因子:5.108刊物:CHEMOSPHERE发表日期:2019/5/18 - TGF-β1-Mediated PD-L1 Glycosylation Contributes to Immune Escape via c-Jun/STT3A Pathway in Nasopharyngeal Carcinoma
影响因子:5.738刊物:Frontiers in Oncology发表日期:2022/3/4 - An electrochemical biosensor for the assessment of tumor immunotherapy based on the detection of immune checkpoint protein programmed death ligand-1
影响因子:12.545刊物:BIOSENSORS & BIOELECTRONICS发表日期:2022/3/7 - Study on the Mechanism of Improving HIV/AIDS Immune Function with Jian Aikang Concentrated Pill Based on Network Pharmacology Combined with Experimental Validation
影响因子:4.319刊物:Drug Design Development and Therapy发表日期:2022/8/18 - An intronic polymorphism of NFATC1 gene shows a risk association with biopsy-proven acute rejection in renal transplant recipients
影响因子:3.297刊物:Annals of Translational Medicine发表日期:2020/3/1 - Distinct roles of programmed death ligand 1 alternative splicing isoforms in colorectal cancer
影响因子:4.966刊物:CANCER SCIENCE发表日期:2020/10/15 - Metabolic Reprogramming of CD4+ T Cells by Mesenchymal Stem Cell-Derived Extracellular Vesicles Attenuates Autoimmune Hepatitis Through Mitochondrial Protein Transfer
影响因子:6.6刊物:International Journal of Nanomedicine发表日期:2024-09-22 - A nanobody-guided multifunctional T cell engager promotes strong anti-tumor responses via synergistic immuno-photothermal effects
影响因子:10.6刊物:JOURNAL OF NANOBIOTECHNOLOGY发表日期:2024-09-14 - Blocking the PD-1 signal transduction by occupying the phosphorylated ITSM recognition site of SHP-2
影响因子:8刊物:Science China-Life Sciences发表日期:2024-08-29 - Immunomodulatory effect of PLGA-encapsulated mesenchymal stem cells-derived exosomes for the treatment of allergic rhinitis
影响因子:5.7刊物:Frontiers in Immunology发表日期:2024-07-08 - IMT030122, A novel engineered EpCAM/CD3/4-1BB tri-specific antibody, enhances T-cell recruitment and demonstrates anti-tumor activity in mouse models of colorectal cancer
影响因子:4.8刊物:INTERNATIONAL IMMUNOPHARMACOLOGY发表日期:2024-06-14 - Self-reinforcing nano-spearhead drives the efficacy of CAR-T cells against progressive triple negative breast cancer
影响因子:21.1刊物:Materials Today发表日期:2024-05-28 - Lyophilized lymph nodes for improved delivery of chimeric antigen receptor T cells
影响因子:37.2刊物:NATURE MATERIALS发表日期:2024-03-06 - IGFBP3 induces PD-L1 expression to promote glioblastoma immune evasion
影响因子:5.3刊物:Cancer Cell International发表日期:2024-02-07 - Prognostic biomarker DARS2 correlated with immune infiltrates in bladder tumor
影响因子:5.7刊物:Frontiers in Immunology发表日期:2024-01-17 - Mitochondrial isocitrate dehydrogenase impedes CAR T?cell function by restraining antioxidant metabolism and histone acetylation
影响因子:27.7刊物:Cell Metabolism发表日期:2024-01-02 - A programmable protease-based protein secretion platform for therapeutic applications
影响因子:14.8刊物:Nature Chemical Biology发表日期:2023-10-23 - Targeting and cytotoxicity of chimeric antigen receptor T cells grafted with PD1 extramembrane domain
影响因子:10.9刊物:Experimental Hematology & Oncology发表日期:2023-09-30 - A dendritic/tumor fusion cell vaccine enhances efficacy of nanobody-based CAR-T cells against solid tumor
影响因子:12.4刊物:Theranostics发表日期:2023-09-18 - A role of NR4A2 in Graves’ disease: regulation of Th17/Treg
影响因子:3.7刊物:ENDOCRINE发表日期:2023-08-31 - DCTPP1, a Reliable Q-Biomarker for Comprehensive Evaluation of the Quality of Tripterygium Glycoside Tablets Based on Chemical References
影响因子:7.9刊物:PHYTOMEDICINE发表日期:2023-07-23 - CD24 is a novel target of chimeric antigen receptor T cells for the treatment of triple negative breast cancer
影响因子:5.8刊物:CANCER IMMUNOLOGY IMMUNOTHERAPY发表日期:2023-07-07 - Universal chimeric Fcγ receptor T cells with appropriate affinity for IgG1 antibody exhibit optimal antitumor efficacy
影响因子:14.5刊物:Acta Pharmaceutica Sinica B发表日期:2023-02-08 - Azithromycin attenuates wheezing after pulmonary inflammation through inhibiting histone H3K27me3 hypermethylation mediated by EZH2
影响因子:5.7刊物:Clinical Epigenetics发表日期:2023-01-23 - A metagenome-wide association study of the gut microbiota in recurrent aphthous ulcer and regulation by thalidomide
影响因子:8.786刊物:Front Immunol. 2022 Oct 19;13:1018567. - Distinct roles of programmed death ligand 1 alternative splicing isoforms in colorectal cancer
刊物:Cancer Sci. 2021 Jan;112(1):178-193. - Increased Antitumor Activities of Glypican-3-Specific Chimeric Antigen Receptor-Modified T Cells by Coexpression of a Soluble Pd1-Ch3 Fusion Protein
刊物:Cancer immunology, immunotherapy : CII 67, 1621-1634 (2018) - Recombination of a Dual-Car-Modified T Lymphocyte to Accurately Eliminate Pancreatic Malignancy
刊物:Journal of hematology & oncology 11, 102 (2018)